Ayurvedic nasal treatments using herbal paste, medicated oil drops, and oral tablets to relieve nasal blockage, loss of smell, sneezing, and runny nose in patients with nasal mass.

A CLINICAL STUDY ON THE EFFICACY OF CHITRAKA KSHARA PRATISARANA KARAVIRADHYA MARSHA NASYA AND KSHARA GUTIKA IN NASA ARSHA WITH SPECIAL REFERENCE TO NASAL POLYPOSIS A SINGLE ARM STUDY - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/12/099472

Enrollment

Registered

2025-12-19

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J330- Polyp of nasal cavity

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. All diagnosed patients of Nasal Polyps having sign and symptoms of Nasa Arsha like Atyadhik pratishyaya, Kshyavahu, Krichho swasa-uchwasa, Putinasya, Anunasika, etc. 2. Patients aged between 16-60 years. 3. Patients with associated conditions, such as Chronic rhinosinusitis with Nasal Polyposis (CRSwNP). 4. Patients not currently on systemic corticosteroids or immunotherapy in the last 4 weeks. 5. Patients who provide informed consent for the study. 6. Able to comply with follow-ups and study protocols.

Exclusion criteria

Exclusion criteria: 1. Patient having Sinonasal malignancies (e.g., squamous cell carcinoma, adenocarcinoma), Olfactory neuroblastoma. 2. Patients who have undergone recent nasal surgery within a span of one month. 3. Patient using systemic corticosteroids. 4. Patients with uncontrolled comorbidities like Hypertension , Diabetes, Bronchial Asthma etc. 5. Patient unfit for Nasya and Kshara Pratisarana. 6. Patient who has been already in any kind of experimental drug study. 7. Patients with cognitive impairment, non-compliance, or inability to provide informed consent. 8. Systemic illness, acute URTI, fungal rhinosinusitis etc.

Design outcomes

Secondary

Measure	Time frame
Reduction in polyp size, assessed through the Endoscopic Nasal Polyp Score (NPS)Timepoint: 21 Days	—

Primary

Measure	Time frame
Improvement in symptoms as measured by the Sino-Nasal Outcome Test (SNOT-22) score.Timepoint: 21 Days	—

Countries

India

Contacts

Public ContactProf Dr Shamsa Fiaz

National Institute of Ayurveda, Jaipur, Rajasthan

shamsa_fiaz@yahoo.com8764009846

Outcome results